1. Home
  2. AQST vs YSG Comparison

AQST vs YSG Comparison

Compare AQST & YSG Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • AQST
  • YSG
  • Stock Information
  • Founded
  • AQST 2004
  • YSG 2016
  • Country
  • AQST United States
  • YSG China
  • Employees
  • AQST 135
  • YSG N/A
  • Industry
  • AQST Biotechnology: Pharmaceutical Preparations
  • YSG Package Goods/Cosmetics
  • Sector
  • AQST Health Care
  • YSG Consumer Discretionary
  • Exchange
  • AQST Nasdaq
  • YSG Nasdaq
  • Market Cap
  • AQST 274.4M
  • YSG 306.5M
  • IPO Year
  • AQST 2018
  • YSG 2020
  • Fundamental
  • Price
  • AQST $3.01
  • YSG $3.88
  • Analyst Decision
  • AQST Strong Buy
  • YSG
  • Analyst Count
  • AQST 8
  • YSG 0
  • Target Price
  • AQST $10.38
  • YSG N/A
  • AVG Volume (30 Days)
  • AQST 2.0M
  • YSG 79.3K
  • Earning Date
  • AQST 03-05-2025
  • YSG 02-25-2025
  • Dividend Yield
  • AQST N/A
  • YSG N/A
  • EPS Growth
  • AQST N/A
  • YSG N/A
  • EPS
  • AQST N/A
  • YSG N/A
  • Revenue
  • AQST $58,900,000.00
  • YSG $472,960,724.00
  • Revenue This Year
  • AQST $18.44
  • YSG $2.29
  • Revenue Next Year
  • AQST N/A
  • YSG $5.70
  • P/E Ratio
  • AQST N/A
  • YSG N/A
  • Revenue Growth
  • AQST 22.56
  • YSG N/A
  • 52 Week Low
  • AQST $2.24
  • YSG $1.99
  • 52 Week High
  • AQST $6.23
  • YSG $5.22
  • Technical
  • Relative Strength Index (RSI)
  • AQST 43.29
  • YSG 61.52
  • Support Level
  • AQST $2.95
  • YSG $3.12
  • Resistance Level
  • AQST $3.21
  • YSG $4.27
  • Average True Range (ATR)
  • AQST 0.20
  • YSG 0.22
  • MACD
  • AQST 0.02
  • YSG 0.11
  • Stochastic Oscillator
  • AQST 18.42
  • YSG 66.09

About AQST Aquestive Therapeutics Inc.

Aquestive Therapeutics Inc is a specialty pharmaceutical company engaged in developing and commercializing differentiated products to meet medical needs. Its later-stage product pipeline focuses on the treatment of diseases of the Central Nervous System (CNS), and an earlier-stage pipeline for the treatment of severe allergic reactions, including anaphylaxis. Its commercial product portfolio includes Sympazan Oral Film, Suboxone Sublingual Film, Exservan Oral Film, and Zuplenz. The product pipeline includes Libervant Buccal Film, AQST-108, and AQST-305. The majority of its revenue comes from the United States.

About YSG Yatsen Holding Limited

Yatsen Holding Ltd is engaged in the retail business of beauty products, skincare items, and other cosmetic products. The Group's principal operations are currently organized into three segments on a product category basis, namely Color Cosmetics Brands, Skincare Brands, and others. The company's majority of revenue is generated from sales of Color Cosmetics Brands.

Share on Social Networks: